2010 - TTS International Congress


This page contains exclusive content for the member of the following sections: TTS. Log in to view.

Surgery and Imaging Advances

76.30 - Laparoscopic Incisional Hernia Repair in organ-transplanted patients: The method of choice

Presenter: Ole, Øyen, Oslo, Norway
Authors: Horneland R., Lien B., Lambrecht J., Øyen O.

LAPAROSCOPIC INCISIONAL HERNIA REPAIR IN ORGAN-TRANSPLANTED PATIENTS: THE METHOD OF CHOICE

SURGERY AND IMAGING - ADVANCES

R. Horneland1, B.H. Lien1, J. Lambrecht2, O. Øyen1
1Dep. For Transplant Surgery, Oslo University Hospital Rikshospitalet, Oslo/NORWAY, 2Surgical Dep., Innlandet Hospital Gjøvik, Gjøvik/NORWAY

Body: Introduction: Due to the immunosuppressive theraphy, incisional hernias are overrepresented in the transplanted population – and recurrences are common.
Minimally invasive procedures have in recent years gained widespread acceptance. Regarding incisonal hernia repair, the laparoscopic, minimally invasive procedure is now buy many considered ‘the gold standard’. The potential benefits of reducing incisions/tissue trauma would be suspected to be even greater in immunosuppressed patients. By avoiding the convential incision above the mesh, troublesome fluid accumulations, causing secretion and potentially infection, are greatly reduced.
Methods: As part of a multicentre study on laparoscopic incisional hernia repair, patients were randomised to +/÷ hernia raphi and mesh fixation (Parietex Composite Mesh) with either ‘transfascial sutures + single crown of tackers’ or ’double crown’ of tackers (4 groups; all laparoscopic) (Figure 1). The present series represent a sub-cohort of transplanted/immunosupprressed patients.
Results: Thirtytwo patients have been included. We hereby present the overall results (all randomisation groups pooled) of this transplanted cohort (Table 1), as no significant differences have been found between the various raphi/mesh fixation techniques. The technical-surgical differences between the groups were in reality minor, in part because raphi, in many cases, was not feasible/unattractive. Conclusions: Our rate of major postoperative complications., in an immunosuppressed series of patients, is low. And, a recurrence rate below 10% must be considered very satisfactory, as reports in the literature describe 15-50% recurrences - though a reservation has to made due to the short observational time.
Nevertheless, we feel confident to conclude that the minimally invasive procedure seems particularly rationale in immunosuppressed patients, with significantly retarded wound healing, and should be the method of choice in this population. [Video-presentation]

Table 1; Results Laparoscopic hernia repair w/ Mesh implantation n = 32
Age (years) 56 [37-69]
BMI (kg/m2) 28 [19-33]
Previouos Kidney-Tx 17 (+ Heart-Tx 1)
Previous Liver-Tx 15 (+ Kidney-Tx 1)
Previous hernia repair 5
Hernia (defect) size; length x width (cm) 10,5 [2,5-25] x 8,7 [2,5-20]
Op. time (min) 117 [45-220]
Conversions 1 (to secure sufficient edge towards kidney graft)
Perop. Incidents Intestinal perforations: 2 (both handled laparoscopically)
Postop. Interventions Percut. drainage of seroma: 1 (3,1%)
Reoperations Removal of tackers in bladder wa1l: 1 (3,1%)
Hospital stay (days) 5 [2-9]
Hernia Recurrences 2 (6,3%)
Mesh protrusion 1 (3,1%)
Observation time (mts) 19 [3-36] (All patients examined 3 mts postop.)

Disclosure: All authors have declared no conflicts of interest.


Important Disclaimer

By viewing the material on this site you understand and accept that:

  1. The opinions and statements expressed on this site reflect the views of the author or authors and do not necessarily reflect those of The Transplantation Society and/or its Sections.
  2. The hosting of material on The Transplantation Society site does not signify endorsement of this material by The Transplantation Society and/or its Sections.
  3. The material is solely for educational purposes for qualified health care professionals.
  4. The Transplantation Society and/or its Sections are not liable for any decision made or action taken based on the information contained in the material on this site.
  5. The information cannot be used as a substitute for professional care.
  6. The information does not represent a standard of care.
  7. No physician-patient relationship is being established.

Social

Contact

Staff Directory
+1-514-874-1717
info@tts.org

Address

The Transplantation Society
International Headquarters
740 Notre-Dame Ouest
Suite 1245
Montréal, QC, H3C 3X6
Canada